TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Rockwell Med ( (RMTI) ) just unveiled an update.
On November 12, 2025, Rockwell Medical, Inc. released an updated corporate presentation. This update is part of their ongoing efforts to provide stakeholders with current information, though it is not considered filed under the Securities Exchange Act of 1934.
The most recent analyst rating on (RMTI) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Rockwell Med stock, see the RMTI Stock Forecast page.
Spark’s Take on RMTI Stock
According to Spark, TipRanks’ AI Analyst, RMTI is a Neutral.
Rockwell Medical’s overall stock score is primarily influenced by its financial performance and technical analysis. The company faces significant profitability challenges and bearish technical indicators. While there are positive signs from the earnings call, such as improved cash position and long-term contracts, the negative valuation and recent revenue decline weigh heavily on the overall score.
To see Spark’s full report on RMTI stock, click here.
More about Rockwell Med
Average Trading Volume: 1,475,004
Technical Sentiment Signal: Strong Sell
Current Market Cap: $36.84M
For an in-depth examination of RMTI stock, go to TipRanks’ Overview page.